Edition:
United Kingdom

Leap Therapeutics Inc (LPTX.OQ)

LPTX.OQ on NASDAQ Stock Exchange Global Market

2.33USD
18 Mar 2019
Change (% chg)

$0.08 (+3.56%)
Prev Close
$2.25
Open
$2.91
Day's High
$2.96
Day's Low
$2.11
Volume
2,494,961
Avg. Vol
106,804
52-wk High
$10.25
52-wk Low
$1.36

Chart for

About

Leap Therapeutics, Inc., formerly HealthCare Pharmaceuticals, Inc., is a clinical-stage biopharmaceutical company. The Company engages in acquiring and developing therapeutics in cancer biology. Its lead product candidates for use in clinical trials include TRX518 and DKN-01. DKN-01 is a monoclonal antibody targeting Dickkopf-re... (more)

Overall

Beta: --
Market Cap(Mil.): $50.10
Shares Outstanding(Mil.): 9.40
Dividend: --
Yield (%): --

Financials

  LPTX.OQ Industry Sector
P/E (TTM): -- 69.32 32.54
EPS (TTM): -3.51 -- --
ROI: -4,400.15 8.89 13.82
ROE: -- 10.00 15.25

Earnings vs. Estimates